Nabi-HB hepatitis B intravenous immune globulin regulatory update

The FDA accepted for priority review a BLA for Nabi-HB to prevent hepatitis B virus (HBV) infection of transplanted livers in HbsAg-positive liver transplant patients. The product already is approved ...